Understanding immune responses to SARS-CoV-2
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-10688356
This study is looking at how our immune system reacts to the virus that causes COVID-19, to understand which responses help protect us and which might cause problems, by examining blood samples from COVID-19 patients over time.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10688356 on ClinicalTrials.gov |
What this research studies
This research focuses on the immune responses to the SARS-CoV-2 virus, which causes COVID-19. It aims to differentiate between immune responses that protect against the virus and those that may lead to disease complications. The study involves analyzing blood samples from COVID-19 patients over time to evaluate various immune responses, including T cell and antibody responses. By using advanced techniques like flow cytometry, researchers will investigate specific immune cell types and their roles in the infection process.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been diagnosed with COVID-19 and are willing to provide blood samples for analysis.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those who are not willing to participate in blood sample collection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of COVID-19 immunity and inform better treatment and prevention strategies.
How similar studies have performed: Other research has shown success in understanding immune responses to viral infections, making this approach promising and relevant.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KLEIN, SABRA L. — JOHNS HOPKINS UNIVERSITY
- Study coordinator: KLEIN, SABRA L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.